Journal News

Saving the bees with proteomics

Elizabeth Stivison
Nov. 10, 2022

You’ve probably heard about the bees dying. About a third of the world’s food depends on pollinators such as bees, wasps, ants and butterflies — and we are losing them.

A researcher collects naturally mite-resistant bees in the wild to bring back to the University of California, Riverside.
Boris Baer
A researcher collects naturally mite-resistant bees in the wild to bring
back to the University of California, Riverside.

Boris Baer, professor for pollinator health at the Center for Integrated Bee Research at the University of California, Riverside, is an expert on this problem, and in a recent paper in the journal Molecular & Cellular Proteomics, he and his team describe how they have used proteomics creatively to help solve the pollinator crisis.

Many factors are hurting pollinators, including climate change, habitat loss and pesticide use. “We are losing all pollinators,” Baer said. “But in the case of the bees, we are aware of it because beekeepers record the losses.”

The U.S. has lost about two-thirds of its bee population since World War II; sometimes we resort to flying bees in from Australia or, as temperatures rise, even putting ice on top of hives so the wax doesn’t melt.

Among the many threats to pollinators is one specific to honeybees: the mite Varroa destructor, which has infested most of the world’s managed bee populations, weakening or killing whole colonies with the disease varroosis. And as if that weren’t bad enough, mites also can act as vectors for other diseases.

In hives at the University of California, Riverside, bee species collected in the wild and bees from managed populations are kept side by side to compare how they respond to stress, including the Varroa destructor mite.
Boris Baer
In hives at the University of California, Riverside, bee species collected in the wild and bees from managed populations are kept side by side to compare how they respond to stress, including the Varroa destructor mite.

“It’s all doom and gloom. Why do we even continue to live on?” Baer said half-jokingly as he described this crisis. But he is, in fact, doing something about it.

In his recent paper, Baer, collaborating with researchers in Ethiopia and China, compared three types of bees: the European honeybee, which is susceptible to the mite and is the honeybee most common in the U.S., and the African and Eastern honeybees (from Ethiopia and China, respectively), which are naturally resistant to the mite.

The researchers used proteomics to study this naturally occurring resistance and to begin identifying what factors may protect bees. They hope that down the line, beekeepers can use this information to breed resistant bees.

This electron microscope image shows a Varroa destructor mite on a honeybee.
USDA/Wikimedia Commons
This electron microscope image shows a Varroa destructor mite on a honeybee.

Baer hypothesized that the immune response of resistant bees might be different from that of susceptible bees. “Bees have immune systems,” he said. “Bees can defend themselves. You just have to have the right bee.”

Using bees of all three types, the lab exposed half of each type to mites and then compared the proteomes in the hemolymph (bee blood), identifying almost 2,000 proteins. As they had hoped, they found variation between those they had exposed to the mites and those they had not. Crucially, they also found variation between the types of bees.

When the researchers sorted through the data, the two resistant bee genotypes showed an enrichment of proteins related to the immune system and detoxification. This supported the team’s hypothesis and could indicate that the resistant bees are mounting a stronger or different immune response to V. destructor, making it harder for the mites to take hold.

Baer’s lab is planning next to figure out what exactly these particular proteins do and possibly set up a breeding program informed by this data. They also hope to study the Africanized bee, a hybrid cross between the susceptible European bee and the protected African bee that also shows resistance.

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
Elizabeth Stivison

Elizabeth Stivison is an ASBMB Today columnist and an assistant laboratory professor at Middlebury College.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

Light-activated small molecule could transform eye infection treatment
News

Light-activated small molecule could transform eye infection treatment

April 21, 2026

Contact lenses raise the risk of infectious keratitis, a leading cause of blindness worldwide. A biotech company is commercializing a light-activated therapy using a ROS-generating molecule to rapidly kill microbes in the cornea to preserve vision.

The molecular orchestra of memory
Feature

The molecular orchestra of memory

April 16, 2026

Calcium, calmodulin and calcium/calmodulin-dependent kinase II form a molecular axis that turns fleeting neural activity into lasting memories. New research shows how memories are stabilized, and possibly even protected or repaired.

Differences in pili structure modulate bacterial behavior
Journal News

Differences in pili structure modulate bacterial behavior

April 14, 2026

Researchers demonstrate how small changes in the structure of hair-like protein appendages can affect the behavior of Acinetobacter bacteria.

Cholesterol regulatory genes predict liver transplant outcomes
Journal News

Cholesterol regulatory genes predict liver transplant outcomes

April 10, 2026

Researchers identify a link between cholesterol-regulating genes and liver transplant success, which could improve donor screening and patient outcomes.

Lipid signatures for a rare neurological disorder
Journal News

Lipid signatures for a rare neurological disorder

April 10, 2026

Researchers find distinct lipid patterns linked to a rare autoimmune neurological disorder, offering hope for effective targeted therapies for patients.

Disease-linked mutations disrupt protein phase behavior
Journal News

Disease-linked mutations disrupt protein phase behavior

April 9, 2026

Researchers find that pathogenic missense mutations are enriched threefold in phrase-separating intrinsically disordered regions of proteins.